Google search, Google maps, Google Glass... Google biotech?
It may seem like a departure from the tech giant's existing business, but Google (NASDAQ:GOOGL) announced yesterday that it will help fund a new health-care company called Calico, which will target diseases related to aging. Details on the company's strategy, research and development process, and how much Google will be investing in the project are still unknown. However, biotech enthusiasts have a number of reasons to be excited about, namely the man who will be taking the helm of this new venture. In the following segment from The Motley Fool's health-care show Market Checkup, analyst Max Macaluso discusses what he thinks the company will be doing and what the impact is for investors today.
Alison Southwick owns shares of Apple. David Williamson has no position in any stocks mentioned. Max Macaluso, Ph.D. owns shares of Apple. The Motley Fool recommends and owns shares of Apple and Google. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Alphabet Investors Don't Care About Voting Rights Anymore
Take a closer look at its two publicly traded classes of stock.
3 Companies Using Artificial Intelligence to Their Advantage
The companies' stocks could benefit as they take advantage of multibillion-dollar opportunities.
My 3 Biggest Stock Holdings
Netflix, Micron Technology, and Alphabet are crowding out all other tickers in this investor's real-money portfolio. Here's how, why, and what they're up to next.